EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Using Microphysiological System for the Development of Treatments for Joint Inflammation and Associated Cartilage Loss—A Pilot Study

Meagan J Makarczyk, Sophie Hines, Haruyo Yagi, Zhong Alan Li iD, Alyssa M Aguglia, Justin Zbikowski, Anne-Marie Padget, Qi Gao iD, Bruce A Bunnell iD, Stuart B Goodman iD, Hang Lin

Biomolecules · 2023

DOI: 10.3390/biom13020384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Meagan J Makarczyk und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, 450 Technology Drive, Rm 217, Pittsburgh, PA 15219, USA. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 7, Osteoarthritis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIBIB NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a painful and disabling joint disease affecting millions worldwide. The lack of clinically relevant models limits our ability to predict therapeutic outcomes prior to clinical trials, where most drugs fail. Therefore, there is a need for a model that accurately recapitulates the whole-joint disease nature of OA in humans. Emerging microphysiological systems provide a new opportunity. We recently established a miniature knee joint system, known as the miniJoint, in which human bone-marrow-derived mesenchymal stem cells (hBMSCs) were used to create an osteochondral complex, synovial-like fibrous tissue, and adipose tissue analogs. In this study, we explored the potential of the miniJoint in developing novel treatments for OA by testing the hypothesis that co-treatment with anti-inflammation and chondroinducing agents can suppress joint inflammation and associated cartilage degradation. Specifically, we created a “synovitis”-relevant OA model in the miniJoint by treating synovial-like tissues with interleukin-1β (IL-1β), and then a combined treatment of oligodeoxynucleotides (ODNs) suppressing the nuclear factor kappa beta (NF-κB) genetic pathway and bone morphogenic protein-7 (BMP-7) was introduced. The combined treatment with BMP-7 and ODNs reduced inflammation in the synovial-like fibrous tissue and showed an increase in glycosaminoglycan formation in the cartilage portion of the osteochondral complex. For the first time, this study demonstrated the potential of the miniJoint in developing disease-modifying OA drugs. The therapeutic efficacy of co-treatment with NF-κB ODNs and BMP-7 can be further validated in future clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic Protein 7OsteoarthritisHumansPilot ProjectsNF-kappa BMicrophysiological SystemsCartilage

Stichwörter der Autor:innen

BMP-7DMOADsinflammationmicrophysiological systemosteoarthritistissue chip

Substanzen

Bone Morphogenetic Protein 7NF-kappa B

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, 450 Technology Drive, Rm 217, Pittsburgh, PA 15219, USA.
  • Department of Bioengineering, University of Pittsburgh Swanson School of Engineering, 450 Technology Drive, Rm 217, Pittsburgh, PA 15219, USA.
  • Department of Orthopaedic Surgery, Stanford University, Stanford, CA 94350, USA.
  • Department of Microbiology, Immunology, and Genetics University of North Texas Health Science Center, Fort Worth, TX 76107, USA.

ORCID-Profile: Zhong Alan Li, Qi Gao, Bruce A Bunnell, Stuart B Goodman

Förderung

  • NCATS NIH HHS
  • NIBIB NIH HHS
  • National Institutes of Health
  • US Department of Defense

Zitieren

APA

Makarczyk, M. J., Hines, S., Yagi, H., Li, Z. A., Aguglia, A. M., Zbikowski, J., Padget, A. M., Gao, Q., Bunnell, B. A., Goodman, S. B., & Lin, H. (2023). Using Microphysiological System for the Development of Treatments for Joint Inflammation and Associated Cartilage Loss—A Pilot Study. Biomolecules. https://doi.org/10.3390/biom13020384

Vancouver

Makarczyk MJ, Hines S, Yagi H, Li ZA, Aguglia AM, Zbikowski J, et al. Using Microphysiological System for the Development of Treatments for Joint Inflammation and Associated Cartilage Loss—A Pilot Study. Biomolecules. 2023. doi:10.3390/biom13020384

BibTeX
@article{Makarczyk2023,
  author = {Makarczyk, Meagan J and Hines, Sophie and Yagi, Haruyo and Li, Zhong Alan and Aguglia, Alyssa M and Zbikowski, Justin and Padget, Anne-Marie and Gao, Qi and Bunnell, Bruce A and Goodman, Stuart B and Lin, Hang},
  title = {Using Microphysiological System for the Development of Treatments for Joint Inflammation and Associated Cartilage Loss—A Pilot Study},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13020384}
}
Kostenlos starten →